Hogan Lovells: What Trump’s Executive Order means for cannabis research

Zuber Lawler: Schedule III Cannabis: FDA’s New Frontier

Schedule III Cannabis: FDA’s New Frontier Schedule III Cannabis: FDA’s New Frontier Article by: Raza Lawrence and Ivy Perez-Bader Federal cannabis rescheduling has been widely discussed as a tax, banking, and criminal-law inflection point. Far less attention has been...